Specific Technology Development: In this model, Isofoton contracts with universities or other companies to develop a specific technology. Isofoton insists on retaining one hundred percent ownership of IPRs in order to have first call in any subsequent exploitation. The company does, however, leave open to its partners the possibility of exploiting the development themselves, provided this does not cut across Isofoton’s own strategic interests. Such possibilities are subject to Isofoton’s prior consent.